Israel’s PolyPid Revives $80 Million NASDAQ IPO Plan

Israel’s PolyPid, which develops an antibiotic coating for bone repair, is reinitiating plans for an IPO. It hopes to raise $18 – $22 million for a company valuation of as much as $80 million. After More...

Antibiotic Coating for Bone Repair PolyPid Postpones IPO

PolyPid, which develops an antibiotic coating for bone repair, has delayed its IPO. The company had planned to raise as much as $24 million from its public offering. The head of the cHealth innovation fund More...

PolyPid Hopes to Raise $24 Million in a NASDAQ IPO

PolyPid, which develops an antibiotic coating for bone repair, has filed with the SEC for an initial public offering on the NASDAQ in which it hopes to raise $24 million. This could leave the company with More...